• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎盘植入谱系疾病 - 英国和法国临床实践和产妇发病率的差异:基于人群的比较研究。

Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.

机构信息

National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Université de Paris, CRESS U1153, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology (EPOPé) Research Team, Paris, France.

出版信息

BJOG. 2022 Sep;129(10):1676-1685. doi: 10.1111/1471-0528.17169. Epub 2022 Apr 29.

DOI:10.1111/1471-0528.17169
PMID:35384244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9544707/
Abstract

OBJECTIVE

To compare the management and outcomes of women with placenta accreta spectrum (PAS) in France and the UK.

DESIGN

Two population-based cohorts.

SETTING

All obstetrician-led hospitals in the UK and maternity hospitals in eight French regions.

POPULATION

A cohort of 219 women with PAS in France and a cohort of 154 women with PAS in the UK.

METHODS

The management and outcomes of women with PAS were compared between the UK and France.

MAIN OUTCOME MEASURES

Median blood loss, severe postpartum haemorrhage (≥3 l), postpartum infection and damage to surrounding organs.

RESULTS

The management of PAS differed between the two countries: a larger proportion of women with PAS in the UK had a caesarean hysterectomy compared with France (43% vs 26%, p < 0.001), whereas in France a larger proportion of women with PAS received a uterus-preserving approach compared with the UK (36% vs 19%, p < 0.001). The total median blood loss in the UK was 3 l (IQR 1.7-6.5 l), compared with 1 l (IQR 0.5-2.5 l) in France; more women with PAS had a severe postpartum haemorrhage (PPH) in the UK compared with women with PAS in France (58% vs 21%, p < 0.001) [Correction added on 06 May 2022, after first online publication: '24 hour' has been changed to 'total' in the preceding sentence]. There was no difference between the UK and French populations for postpartum infection or organ damage.

CONCLUSIONS

The UK and France have very different approaches to managing PAS, with more women in France receiving a uterine-conserving approach and more women in the UK undergoing caesarean hysterectomy. A life-threatening haemorrhage was more common in the UK than in France, which may be the result of differential management and/or the organisation of the healthcare systems. In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.

TWEETABLE ABSTRACT

In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France.

摘要

目的

比较法国和英国胎盘部位滋养细胞肿瘤(PAS)患者的管理和结局。

设计

两项基于人群的队列研究。

设置

英国所有产科医生主导的医院和法国 8 个地区的产科医院。

人群

法国 PAS 患者队列中有 219 例,英国 PAS 患者队列中有 154 例。

方法

比较英国和法国 PAS 患者的管理和结局。

主要观察指标

中位出血量、严重产后出血(≥3 升)、产后感染和周围器官损伤。

结果

两国 PAS 的管理方式不同:英国 PAS 患者行剖宫产子宫切除术的比例明显高于法国(43%比 26%,p<0.001),而法国 PAS 患者保留子宫的比例明显高于英国(36%比 19%,p<0.001)。英国 PAS 患者总中位出血量为 3 升(IQR 1.7-6.5 升),法国为 1 升(IQR 0.5-2.5 升);英国 PAS 患者发生严重产后出血的比例明显高于法国(58%比 21%,p<0.001)。英国和法国 PAS 患者的产后感染或器官损伤无差异。

结论

英国和法国在 PAS 的管理上有很大的不同,法国有更多的患者接受保留子宫的方法,而英国有更多的患者行剖宫产子宫切除术。英国危及生命的出血比法国更常见,这可能是管理和/或医疗保健系统组织的差异所致。在胎盘部位滋养细胞肿瘤患者中,英国严重出血的比例高于法国。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d05/9544707/62db6950e71e/BJO-129-1676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d05/9544707/62db6950e71e/BJO-129-1676-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d05/9544707/62db6950e71e/BJO-129-1676-g001.jpg

相似文献

1
Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.胎盘植入谱系疾病 - 英国和法国临床实践和产妇发病率的差异:基于人群的比较研究。
BJOG. 2022 Sep;129(10):1676-1685. doi: 10.1111/1471-0528.17169. Epub 2022 Apr 29.
2
The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study.需要大量输注8个或更多单位红细胞的产后出血女性的流行病学及结局:一项全国性横断面研究。
BJOG. 2016 Dec;123(13):2164-2170. doi: 10.1111/1471-0528.13831. Epub 2015 Dec 23.
3
Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: a retrospective single-centre cross-sectional study.组织学证实的胎盘植入谱系疾病妇女产后出血的危险因素:一项回顾性单中心横断面研究。
BMC Pregnancy Childbirth. 2023 Nov 11;23(1):786. doi: 10.1186/s12884-023-06103-5.
4
The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study.英国胎盘植入、植入性胎盘和穿透性胎盘的管理和结局:基于人群的描述性研究。
BJOG. 2014 Jan;121(1):62-70; discussion 70-1. doi: 10.1111/1471-0528.12405. Epub 2013 Aug 7.
5
Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.胎盘植入谱系疾病的保守治疗或剖宫产子宫切除术:PACCRETA前瞻性研究
Am J Obstet Gynecol. 2022 Jun;226(6):839.e1-839.e24. doi: 10.1016/j.ajog.2021.12.013. Epub 2021 Dec 14.
6
BJOG mini commentary on Placenta accreta spectrum - Variations in clinical practice and maternal morbidity between UK and France: A population-based comparative study.《英国妇产科杂志》关于胎盘植入谱系的简短评论——英国和法国临床实践及孕产妇发病率的差异:一项基于人群的比较研究
BJOG. 2022 Sep;129(10):1686. doi: 10.1111/1471-0528.17170. Epub 2022 Apr 20.
7
Patterns of care for women with placenta accreta spectrum.胎盘植入谱系疾病妇女的护理模式。
J Matern Fetal Neonatal Med. 2021 Oct;34(20):3370-3376. doi: 10.1080/14767058.2019.1684471. Epub 2019 Nov 19.
8
Incidence and risk factors for severe postpartum haemorrhage in women with anterior low-lying or praevia placenta and prior caesarean: Prospective population-based study.前置胎盘或低置胎盘且既往剖宫产的妇女产后严重出血的发生率及危险因素:前瞻性基于人群的研究。
BJOG. 2023 Dec;130(13):1653-1661. doi: 10.1111/1471-0528.17554. Epub 2023 May 24.
9
Placenta accreta spectrum: We can do better.胎盘植入谱系疾病:我们可以做得更好。
Aust N Z J Obstet Gynaecol. 2022 Jun;62(3):376-382. doi: 10.1111/ajo.13471. Epub 2022 Jan 4.
10
Uterine conservation in placenta accrete spectrum (PAS) disorders: A retrospective case series: Is expectant management beneficial in reducing maternal morbidity?胎盘植入谱系疾病(PAS)中保留子宫:一项回顾性病例系列研究:期待治疗对降低孕产妇发病率有益吗?
Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:212-217. doi: 10.1016/j.ejogrb.2020.09.029. Epub 2020 Sep 24.

引用本文的文献

1
Differential risk and clinical characteristics of placenta accreta spectrum in twin and singleton pregnancies: implications for perinatal outcomes.双胎妊娠与单胎妊娠胎盘植入谱系的差异风险及临床特征:对围产期结局的影响
J Glob Health. 2025 Aug 22;15:04252. doi: 10.7189/jogh.15.04252.
2
Management and outcomes of women with placenta accreta spectrum grade 3: an INOSS multicountry multiperiod population-based study.胎盘植入谱系3级女性的管理与结局:一项INOSS多国多时期基于人群的研究。
BMC Pregnancy Childbirth. 2025 Apr 7;25(1):401. doi: 10.1186/s12884-025-07271-2.
3
New surgical technique for managing placenta accreta spectrum and pilot study of the "CMNT PAS" study.

本文引用的文献

1
Searching for placenta percreta: a prospective cohort and systematic review of case reports.胎盘植入的探寻:一项前瞻性队列研究及病例报告的系统评价
Am J Obstet Gynecol. 2022 Jun;226(6):837.e1-837.e13. doi: 10.1016/j.ajog.2021.12.030. Epub 2021 Dec 29.
2
Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.胎盘植入谱系疾病的保守治疗或剖宫产子宫切除术:PACCRETA前瞻性研究
Am J Obstet Gynecol. 2022 Jun;226(6):839.e1-839.e24. doi: 10.1016/j.ajog.2021.12.013. Epub 2021 Dec 14.
3
The modified radical peripartum cesarean hysterectomy (Soleymani-Alazzam-Collins technique): a systematic, safe procedure for the management of severe placenta accreta spectrum.
用于处理胎盘植入谱系疾病的新手术技术及“CMNT PAS”研究的初步研究
AJOG Glob Rep. 2024 Dec 10;5(1):100430. doi: 10.1016/j.xagr.2024.100430. eCollection 2025 Feb.
4
Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?回首过去,展望未来:产科医生积极管理胎盘植入谱系疾病的时代是否已经到来?
Int J Gynaecol Obstet. 2025 Jan;168(1):48-56. doi: 10.1002/ijgo.15826. Epub 2024 Jul 24.
5
A Single-Centre Retrospective Analysis of Pregnancies with Placenta Accreta Spectrum (PAS): From One-Step Surgery towards Two-Step Surgical Approach.胎盘植入谱系疾病(PAS)妊娠的单中心回顾性分析:从一期手术到二期手术方法
J Clin Med. 2024 May 30;13(11):3209. doi: 10.3390/jcm13113209.
6
Single-cell and spatial transcriptomics reveal alterations in trophoblasts at invasion sites and disturbed myometrial immune microenvironment in placenta accreta spectrum disorders.单细胞和空间转录组学揭示了胎盘植入谱系障碍中侵袭部位滋养层细胞的改变以及子宫肌层免疫微环境的紊乱。
Biomark Res. 2024 Jun 3;12(1):55. doi: 10.1186/s40364-024-00598-6.
7
Obstetric and haematological management and outcomes of women with placenta accreta spectrum by planned or urgent delivery: Secondary data analysis of a public referral hospital in Lebanon.产科和血液学管理以及计划性或紧急分娩的胎盘植入谱系妇女的结局:黎巴嫩一家公立转诊医院的二次数据分析。
PLoS One. 2024 May 8;19(5):e0302366. doi: 10.1371/journal.pone.0302366. eCollection 2024.
8
Opportunities for, and barriers to, uterus-preserving surgical techniques for placenta accreta spectrum.胎盘植入谱系疾病保留子宫手术技术的机遇与障碍
Acta Obstet Gynecol Scand. 2025 Apr;104 Suppl 1(Suppl 1):8-19. doi: 10.1111/aogs.14855. Epub 2024 May 2.
9
Placenta accreta spectrum - the ongoing evolution of an iatrogenic condition.胎盘植入谱系——一种医源性疾病的不断演变
Case Rep Womens Health. 2023 Jun 19;39:e00521. doi: 10.1016/j.crwh.2023.e00521. eCollection 2023 Sep.
10
Radiomics-based prediction of FIGO grade for placenta accreta spectrum.基于放射组学的胎盘植入谱系 FIGO 分级预测。
Eur Radiol Exp. 2023 Sep 20;7(1):54. doi: 10.1186/s41747-023-00369-2.
改良经剖宫产子宫切除术(Soleymani-Alazzam-Collins 技术):一种系统、安全的严重胎盘植入谱系疾病的处理方法。
Am J Obstet Gynecol. 2021 Aug;225(2):175.e1-175.e10. doi: 10.1016/j.ajog.2021.03.014. Epub 2021 Mar 12.
4
Clinical profiles of placenta accreta spectrum: the PACCRETA population-based study.胎盘植入谱系疾病的临床特征:PACCRETA 基于人群的研究。
BJOG. 2021 Sep;128(10):1646-1655. doi: 10.1111/1471-0528.16647. Epub 2021 Feb 3.
5
FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders.FIGO 分类用于胎盘部位滋养细胞肿瘤的临床诊断。
Int J Gynaecol Obstet. 2019 Jul;146(1):20-24. doi: 10.1002/ijgo.12761.
6
Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta.异常性胎盘植入管理的循证指南:国际异常性胎盘植入学会的推荐意见。
Am J Obstet Gynecol. 2019 Jun;220(6):511-526. doi: 10.1016/j.ajog.2019.02.054. Epub 2019 Mar 5.
7
Are women antenatally diagnosed with abnormally invasive placenta receiving optimal management in England? An observational study of planned place of delivery.英国接受产前诊断的异常侵袭性胎盘的女性是否在接受最佳管理?一项关于计划分娩地点的观察性研究。
Acta Obstet Gynecol Scand. 2019 Mar;98(3):337-341. doi: 10.1111/aogs.13487. Epub 2018 Nov 15.
8
Global epidemiology of use of and disparities in caesarean sections.全球剖宫产使用情况及差异的流行病学研究。
Lancet. 2018 Oct 13;392(10155):1341-1348. doi: 10.1016/S0140-6736(18)31928-7.
9
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a.前置胎盘和胎盘植入:诊断与管理:绿帽指南第27a号
BJOG. 2019 Jan;126(1):e1-e48. doi: 10.1111/1471-0528.15306. Epub 2018 Sep 27.
10
Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons.低年资医师行子宫切除术的结局。
Obstet Gynecol. 2018 Jun;131(6):981-990. doi: 10.1097/AOG.0000000000002597.